|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
|
DE4341156C2
(de)
*
|
1993-12-02 |
1997-11-13 |
Wacker Chemie Gmbh |
Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
|
|
DE4413350A1
(de)
*
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
|
FR2725624B1
(fr)
*
|
1994-10-14 |
1997-01-17 |
Jouveinal Inst Rech |
Procede de preparation de formes pharmaceutiques a liberation controlee
|
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
DE19504832A1
(de)
*
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
|
DE29502547U1
(de)
*
|
1995-02-16 |
1995-03-30 |
Röhm GmbH, 64293 Darmstadt |
Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
|
|
DE19531684A1
(de)
*
|
1995-08-29 |
1997-03-06 |
Bayer Ag |
Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
|
|
DE19631084A1
(de)
*
|
1996-08-01 |
1998-02-05 |
Basf Ag |
Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
|
|
TW474824B
(en)
|
1996-09-13 |
2002-02-01 |
Basf Ag |
The production of solid pharmaceutical forms
|
|
DE19710213A1
(de)
*
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
|
DE19812688A1
(de)
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
|
JP4120977B2
(ja)
*
|
1999-06-04 |
2008-07-16 |
株式会社ジェイテクト |
ステアリングコラム用軸受装置
|
|
FR2795326B1
(fr)
*
|
1999-06-28 |
2001-08-31 |
Adir |
Composition pharmaceutique solide thermoformable a liberation controlee
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
|
DE60028754T2
(de)
*
|
1999-11-12 |
2007-05-31 |
Abbott Laboratories, Abbott Park |
Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
|
|
AU2001263760A1
(en)
|
2000-04-11 |
2001-11-07 |
Polyzenix Gmbh |
Poly-tri-fluoro-ethoxypolyphosphazene coverings and films
|
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
|
EP1179353A1
(de)
*
|
2000-08-11 |
2002-02-13 |
B. Braun Melsungen Ag |
Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
|
|
US20090004240A1
(en)
*
|
2000-08-11 |
2009-01-01 |
Celonova Biosciences, Inc. |
Implants with a phosphazene-containing coating
|
|
HU230875B1
(hu)
|
2000-10-30 |
2018-11-29 |
Euro-Celtique S.A. |
Szabályozott hatóanyag-leadású hidrokodon készítmények
|
|
FR2818552B1
(fr)
*
|
2000-12-26 |
2003-02-07 |
Servier Lab |
Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
|
|
FR2818550B1
(fr)
*
|
2000-12-26 |
2003-02-07 |
Servier Lab |
Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
|
|
FR2818549B1
(fr)
*
|
2000-12-26 |
2003-02-07 |
Servier Lab |
Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
|
|
US9080146B2
(en)
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
|
WO2003015719A1
(de)
*
|
2001-08-17 |
2003-02-27 |
Polyzenix Gmbh |
Vorrichtung auf basis von nitinol mit polyphosphazenüberzug
|
|
US7842308B2
(en)
*
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
|
GB0102342D0
(en)
*
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
US20080138433A1
(en)
*
|
2002-07-05 |
2008-06-12 |
Celonova Biosciences, Inc. |
Vasodilator eluting blood storage and administration devices with a specific polyphosphazene coating and methods for their manufacture and use
|
|
US20050136093A1
(en)
*
|
2002-07-05 |
2005-06-23 |
Polyzenix Gmbh |
Implant for transport and release for pharmacologically active agents as well as a process for producing the same
|
|
US20080138377A1
(en)
*
|
2002-07-05 |
2008-06-12 |
Celonova Biosciences, Inc. |
Vasodilator Eluting Luminal Stent Devices With A Specific Polyphosphazene Coating and Methods for Their Manufacture and Use
|
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
EP1656163B1
(en)
*
|
2003-08-13 |
2014-08-06 |
Poly-Med, Inc. |
Biocompatible controlled release coatings for medical devices and related methods
|
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
|
AR048033A1
(es)
|
2004-03-12 |
2006-03-22 |
Smithkline Beecham Plc |
Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
|
|
US20050238721A1
(en)
*
|
2004-04-07 |
2005-10-27 |
Acquarulo Lawrence A Jr |
One step compounding extrusion of drug filled polymers
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
|
US9107850B2
(en)
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
|
US9114162B2
(en)
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7241805B2
(en)
|
2005-06-27 |
2007-07-10 |
Biovail Laboratories, Inc. |
Modified release formulations of a bupropion salt
|
|
DE102005053066A1
(de)
*
|
2005-11-04 |
2007-05-10 |
Basf Ag |
Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
|
|
US20080300320A1
(en)
*
|
2005-12-09 |
2008-12-04 |
Basf Se |
Use of Polyvinyl Lactam-Polyalkylene Block Copolymers as Solubilisers for Poorly Water-Soluble Compounds
|
|
US7771632B2
(en)
*
|
2006-05-15 |
2010-08-10 |
American Leistritz Extruder Corp. |
Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets
|
|
WO2008045953A2
(en)
*
|
2006-10-10 |
2008-04-17 |
Celonova Biosciences, Inc. |
Compositions and devices comrising silicone and specific polyphosphazenes
|
|
KR101083471B1
(ko)
*
|
2006-10-10 |
2011-11-16 |
셀로노바 바이오사이언시즈, 인코포레이티드 |
폴리포스파젠을 갖는 생체인공심장판막
|
|
CA2669938C
(en)
*
|
2006-11-15 |
2016-01-05 |
Abbott Laboratories |
Solid pharmaceutical dosage formulations
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
CN101765616A
(zh)
*
|
2007-07-26 |
2010-06-30 |
巴斯夫欧洲公司 |
制备通过接枝聚合在溶液中获得的并基于固体聚醚的共聚物的方法
|
|
EP2219624A2
(en)
|
2007-11-08 |
2010-08-25 |
Glaxo Group Limited |
Pharmaceutical formulations
|
|
AU2009207796B2
(en)
|
2008-01-25 |
2014-03-27 |
Grunenthal Gmbh |
Pharmaceutical dosage form
|
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
|
HRP20161307T1
(hr)
|
2008-05-09 |
2016-12-02 |
Grünenthal GmbH |
Postupak za pripravu praškaste formulacije međuproizvoda i konačni kruti oblik doziranja uz korištenje koraka zgrušavanja raspršivanjem
|
|
WO2010022193A2
(en)
|
2008-08-20 |
2010-02-25 |
Board Of Regents, The University Of Texas System |
Hot-melt extrusion of modified release multi-particulates
|
|
CA2765971C
(en)
|
2009-07-22 |
2017-08-22 |
Gruenenthal Gmbh |
Hot-melt extruded controlled release dosage form
|
|
PE20120631A1
(es)
|
2009-07-22 |
2012-06-06 |
Gruenenthal Chemie |
Forma de dosificacion resistente a la manipulacion para opioides sensibles a la oxidacion
|
|
PL2611426T3
(pl)
|
2010-09-02 |
2014-09-30 |
Gruenenthal Gmbh |
Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
|
|
AR082862A1
(es)
|
2010-09-02 |
2013-01-16 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico
|
|
MX341873B
(es)
|
2010-12-23 |
2016-09-06 |
Abbvie Deutschland |
Formulaciones solidas de retardo basadas en dispersiones solidas.
|
|
DE102011018403A1
(de)
*
|
2011-04-21 |
2012-10-25 |
Automatik Plastics Machinery Gmbh |
Verfahren zur Herstellung von pharmazeutischen Erzeugnissen aus einem Schmelzematerial
|
|
KR20140053159A
(ko)
|
2011-07-29 |
2014-05-07 |
그뤼넨탈 게엠베하 |
즉시 약물 방출을 제공하는 탬퍼-저항성 정제
|
|
HRP20171458T1
(hr)
|
2011-07-29 |
2017-11-17 |
Grünenthal GmbH |
Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
|
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
|
PT2838512T
(pt)
|
2012-04-18 |
2018-11-09 |
Gruenenthal Gmbh |
Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
DE102012011894A1
(de)
|
2012-06-15 |
2014-01-02 |
Automatik Plastics Machinery Gmbh |
Verfahren und Vorrichtung zum Granulieren von Schmelzematerial
|
|
BR112015026549A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem à prova de violação contendo uma ou mais partículas
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
EA032465B1
(ru)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
|
|
HK1224189A1
(zh)
|
2013-11-26 |
2017-08-18 |
Grünenthal GmbH |
通过低温研磨制备粉状药物组合物
|
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
WO2015181059A1
(en)
|
2014-05-26 |
2015-12-03 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
HK1246173A1
(zh)
|
2015-04-24 |
2018-09-07 |
Grünenthal GmbH |
具有立即释放和对溶剂萃取的抗性的抗篡改剂型
|
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
AU2018360383A1
(en)
|
2017-11-02 |
2020-05-21 |
Natureceuticals Sdn. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|